A Phase I Trial of Inhaled Iloprost for the Prevention of Lung Cancer in Former Smokers
Phase of Trial: Phase I
Latest Information Update: 16 Aug 2017
At a glance
- Drugs Iloprost (Primary)
- Indications Lung cancer
- Focus Adverse reactions
- 10 Jun 2017 Biomarkers information updated
- 21 Sep 2016 Status changed from suspended to recruiting.
- 20 Jul 2016 Planned number of patients changed from 60 to 61.